0 NASDAQ Companies - April 2, 2025BBSI Announces Appointment of Thomas McGinn as Senior Vice President of InsuranceVANCOUVER, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Barrett Business Services, Inc. (BBSI) (NASDAQ: BBSI), a leading provider of business […]Read More
0 NASDAQ Companies - April 2, 2025Kestra Medical Technologies, Ltd. to Report Third Quarter Fiscal 2025 Financial Results on April 14KIRKLAND, Wash., April 02, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital […]Read More
0 NASDAQ Companies - April 2, 2025NeuroPace Announces Refocusing of Product Portfolio— Beginning of Wind Down of Stereo EEG (SEEG) Distribution Relationship in Q4 2025 — — Maintaining 2025 Revenue Guidance […]Read More
0 NASDAQ Companies - April 2, 2025Verrica Pharmaceuticals Appoints Gavin Corcoran, M.D. to its Board of DirectorsWEST CHESTER, Pa., April 02, 2025 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology […]Read More
0 NASDAQ Companies - April 2, 2025FormFactor Doubles Capacity at Taiwan Service Center to Meet Growing DemandLIVERMORE, Calif., April 02, 2025 (GLOBE NEWSWIRE) — FormFactor, Inc. (NASDAQ: FORM), a leading provider of test and measurement technologies […]Read More
0 NASDAQ Companies - April 2, 2025BioCryst to Present at Upcoming Investor ConferenceRESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans […]Read More
0 NASDAQ Companies - April 2, 2025Bassett Reports Fiscal First Quarter ResultsBASSETT, Va., April 02, 2025 (GLOBE NEWSWIRE) — Bassett Furniture Industries, Inc. (Nasdaq: BSET) reported today its results of operations […]Read More
0 NASDAQ Companies - April 2, 2025First Hawaiian to Report First Quarter 2025 Financial Results on April 23, 2025HONOLULU, April 02, 2025 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its […]Read More
0 NASDAQ Companies - April 1, 2025Telix Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue SarcomaMELBOURNE, Australia, April 02, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX; NASDAQ: TLX, Telix, the Company) today announces […]Read More
0 NASDAQ Companies - April 1, 2025LeMaitre to Present at the 24th Annual Needham Virtual Healthcare ConferenceBURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the […]Read More